Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis.

Abstract

Pulmonary fibrosis is an end-stage disorder for which efficacious therapeutic options are not readily available. Although its pathogenesis is poorly understood, pulmonary fibrosis occurs as a result of various inflammations. NKT cells modulate inflammation because of their ability to produce large amounts of cytokines by stimulation with their glycolipid… (More)

Topics

6 Figures and Tables

Slides referencing similar topics